{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:57:06Z","timestamp":1778853426648,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.cyto.2015.01.002","type":"journal-article","created":{"date-parts":[[2015,2,4]],"date-time":"2015-02-04T05:15:34Z","timestamp":1423026934000},"page":"197-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["The effects of the CXCR2 antagonist, MK-7123, on bone marrow functions in healthy subjects"],"prefix":"10.1016","volume":"72","author":[{"given":"Nina","family":"Hastrup","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sauzanne","family":"Khalilieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Dale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars G.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Magnusson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjela","family":"Tzontcheva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Huyck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Krogsgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"April 28","key":"10.1016\/j.cyto.2015.01.002_b0005","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/ng.2962","article-title":"Rare and low-frequency coding variants in CXCR2 and other genes are associated with hematological traits","volume":"46","author":"Auer","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.cyto.2015.01.002_b0015","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1124\/pr.56.4.2","article-title":"Mediators of chronic obstructive pulmonary disease","volume":"56","author":"Barnes","year":"2004","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.cyto.2015.01.002_b0020","first-page":"359","article-title":"The kinetics of neutrophilic leukocytes in health and in disease","volume":"4","author":"Boggs","year":"1967","journal-title":"Semin Hematol"},{"key":"10.1016\/j.cyto.2015.01.002_b0025","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1124\/jpet.106.119040","article-title":"A novel, orally active CXCR1\/2 receptor antagonist, Sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation","volume":"322","author":"Chapman","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cyto.2015.01.002_b0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pharmthera.2008.10.005","article-title":"CXCR2 antagonists for the treatment of pulmonary disease","volume":"121","author":"Chapman","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.cyto.2015.01.002_b0035","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1056\/NEJM197704072961401","article-title":"Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis","volume":"296","author":"Craddock","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2015.01.002_b0040","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1172\/JCI108517","article-title":"Neutrophil kinetics in man","volume":"58","author":"Dancey","year":"1976","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2015.01.002_b0045","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1172\/JCI41649","article-title":"CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow","volume":"120","author":"Eash","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2015.01.002_b0050","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1200\/JCO.2002.02.140","article-title":"Model of chemotherapy-induced myelosuppression with parameter consistency across drugs","volume":"20","author":"Friberg","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cyto.2015.01.002_b0055","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1124\/jpet.106.118927","article-title":"Pharmacological characterization of Sch527123, a potent allosteric CXCR1\/CXCR2 antagonist","volume":"322","author":"Gonsiorek","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cyto.2015.01.002_b0060","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1124\/jpet.103.063131","article-title":"Cloning and pharmacological characterization of CXCR1 and CXCR2 from Macaca fascicularis","volume":"310","author":"Hipkin","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cyto.2015.01.002_b0065","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1183\/09031936.00048509","article-title":"SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects","volume":"35","author":"Holz","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cyto.2015.01.002_b0070","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1073\/pnas.93.13.6682","article-title":"Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2","volume":"93","author":"Jones","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2015.01.002_b0075","first-page":"613s","article-title":"Rising single-dose safety and pharmacokinetics of oral SCH 527123, a novel antagonist of CXCR2, in healthy volunteers","volume":"30","author":"Khalilieh","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cyto.2015.01.002_b0080","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1182\/blood-2003-02-0663","article-title":"Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist","volume":"102","author":"Liles","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2015.01.002_b0085","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1182\/blood-2013-09-527226","article-title":"A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor","volume":"123","author":"McDermott","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2015.01.002_b0090","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1074-7613(03)00263-2","article-title":"Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence","volume":"19","author":"Martin","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2015.01.002_b0095","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1365-2222.2012.04014.x","article-title":"Safety and ef-ficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutro-phils: a randomized, placebo-controlled clinical trial","volume":"42","author":"Nair","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.cyto.2015.01.002_b0100","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood.V88.1.335.335","article-title":"Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans","volume":"88","author":"Price","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2015.01.002_b0105","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1164\/rccm.200208-794OC","article-title":"Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease","volume":"168","author":"Qiu","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cyto.2015.01.002_b0110","unstructured":"Rennard SI, Dale DC, Donohue J, Kanniess F, Magnussen H, Sutherland E, et al. [abstract] CXCR2 antagonist MK-7123-a phase 2 proof-of-concept trial for chronic obstructive pulmonary disease. Presented at the congress of the American Thoracic Society 2013: Philadelphia, PA; 2013."},{"key":"10.1016\/j.cyto.2015.01.002_b0115","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.intimp.2013.05.029","article-title":"Humoral immunity and delayed-type hypersensitivity in healthy subjects treated for 30days with MK-7123, a selective CXCR2 antagonist","volume":"17","author":"Seiberling","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.cyto.2015.01.002_b0120","doi-asserted-by":"crossref","first-page":"L322","DOI":"10.1152\/ajplung.00039.2005","article-title":"Role of CXCR2 in cigarette smoke-induced lung inflammation","volume":"289","author":"Thatcher","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"10.1016\/j.cyto.2015.01.002_b0125","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/10428190290005982","article-title":"Neutrophil gelantinase B and chemokines in leukocytosis and stem cell mobilization","volume":"V43","author":"Starckx","year":"2002","journal-title":"Leukemia Lymphoma"},{"key":"10.1016\/j.cyto.2015.01.002_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2012.02.016","article-title":"Chemokine receptor CXCR2: physiology regulator and neuroinflammation controller?","volume":"246","author":"Veenstra","year":"2012","journal-title":"J Neuroimmunol"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466615000058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466615000058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T17:05:27Z","timestamp":1598720727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466615000058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S1043466615000058"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2015.01.002","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of the CXCR2 antagonist, MK-7123, on bone marrow functions in healthy subjects","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2015.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}